Serina Therapeutics, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Serina Therapeutics, Inc. (SER) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $173.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-03-25
- Serina Therapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $173.00K.
- Serina Therapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $14.00K, a 39.13% decline from fiscal 2022.
- Serina Therapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $23.00K.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $173.00K 10-K · filed 2026-03-25 |
| 2023-12-31 | $14.00K 10-K · filed 2024-03-22 |
| 2022-12-31 | $23.00K 10-K · filed 2024-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |